Integra Lifesciences Holdings (IART) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | -54.61% |
| 10 | Integra Lifesciences Holdings | 1.52 Bn | 1.26 Bn | 216.98 Mn | 454.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 454.11% |
| Dec 31, 2025 | -30.05% |
| Sep 30, 2025 | 381.82% |
| Jun 30, 2025 | -3,578.97% |
| Mar 31, 2025 | -170.05% |
| Dec 31, 2024 | 131.65% |
| Sep 30, 2024 | -105.57% |
| Jun 30, 2024 | -165.59% |
| Mar 31, 2024 | -88.97% |
| Dec 31, 2023 | 42.16% |
| Sep 30, 2023 | 14.01% |
| Jun 30, 2023 | -60.21% |
| Mar 31, 2023 | 403.42% |
| Dec 31, 2022 | 2.16% |
| Sep 30, 2022 | 161.56% |
| Jun 30, 2022 | -82.05% |
| Mar 31, 2022 | 72.03% |
| Dec 31, 2021 | -40.51% |
| Sep 30, 2021 | -17.57% |
| Jun 30, 2021 | 2,235.29% |